AGY — Allergy Therapeutics Share News
0.000.00%
- £706.27m
- £753.56m
- £55.04m
REG-Abbott Laboratories: Form 8.3 - Allergy Therapeutics PLC
AnnouncementREG - Takeover Panel - Disclosure Table (POTAM only)
AnnouncementREG - Allergy Therapeutics - FORM 8 (OPD) – Allergy Therapeutics plc
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Allergy Therapeutics - Project Zebra Rule 2.9 Announcement
AnnouncementREG - Takeover Panel - Disclosure Table (POTAM only)
AnnouncementREG - Takeover Panel - Disclosure Table (POTAM only)
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Allergy Therapeutics - Skin-prick testing completes in PROTECT Trial
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - ZQ Capital Limited Allergy Therapeutics - Form 8 (OPD) SkyGem Acquisition Limited
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
Announcement